CHRONICLE Study Show Biologic Therapies Promising for Severe Asthma
Since approximately 5% to 10% of patients with asthma have severe disease, there is an urgent need...
Read More
Author: Mukuntha Subburayan
Take Our PhysQuiz on ACR Convergence 2020!
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...
Read MoreCLEAR Trial: Promising New Combination to Treat RCC
In the phase 3 multicenter, open-label, randomized CLEAR trial, lenvatinib in combination with pembrolizumab or everolimus demonstrated significant benefits over sunitinib in patients with advanced renal cell carcinoma (RCC)....
Read MorePhysQuiz Answers! SABCS 2020
1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...
Read More
Take Our PhysQuiz on SABCS 2020!
Test your knowledge on SABCS 2020 – take our quiz and see how you compare with your...
Read More
Significance Of Age And Allergic Versus Non-Allergic Asthma
Childhood and onset of allergic asthma are strongly associated, but only a few studies have...
Read More
NIH Update Includes Four New Recommendations for Allergic Asthma
The National Institutes of Health (NIH) recently announced 19 recommendations for the diagnosis,...
Read MoreUpdate on KEYNOTE-426: Combo Offers Durable Survival Benefit in Patients with Advanced Disease
Pembrolizumab plus axitinib is superior to sunitinib for the treatment of patients with treatment-naïve, advanced renal cell carcinoma (RCC), according to the most recent exploratory analysis of data from the KEYNOTE-426 study....
Read MoreColorectal Cancer; Pediatric Vaccines SAR-Cov-2; Special Needs in Pandemic
[spreaker type=player resource=”episode_id=43864335″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]
Read MorePhysQuiz Answers! AAO 2020 on Dry Eye
Thank you for taking our quiz! How did you do? 1) According to an AAO IRIS® Registry Analysis, the overall prevalence of dry eye disease (DED) was about 30% in patients 3 months prior cataract surgery, but only what percent of...
Read More
Take Our PhysQuiz on Dry Eye
It’s no question that advancements in the treatment of dry eye were impressive at AAO 2020....
Read More
Take Our PhysQuiz on AMD
It’s no question that advancements in the treatment of age-related macular degeneration were...
Read More
Omalizumab: Safe & Effective for Older Patients With Urticaria & Comorbidities
Omalizumab is a safe and effective therapy for elderly patients with urticaria who present with...
Read More
A Look at D-Dimer Concentrations in Acute Urticaria in Children
Researchers found that in a studied group of children, there was a tendency for higher D-dimer...
Read More
Gender Reveal Parties Should No Longer Be a Thing
By Physician’s Weekly Blogger, Skeptical Scalpel Pop quiz: In the last 5years, how many people...
Read More
Is Non-Allergic Severe Asthma Always Non-Allergic?
Differential diagnosis of allergic versus non-allergic asthma is typically made on the basis of...
Read More
Allergen Immunotherapy for Allergic Asthma in Real World Practice
Allergen immunotherapy (AIT) induces immunological tolerance, and there is increasing evidence of...
Read MorePhysician’s Weekly Podcast: Warren vs Dinter
Warren vs Dinter – Interview with Dr. MedLaw
Read MorePW Podcast: Fatty Liver, COVID-19 and Psoriasis, and Variants of SARS-CoV-2
[spreaker type=player resource=”episode_id=43624976″ theme=”light” autoplay=”false” playlist=”false” width=”100%” height=”200px”]
Read More